nodes	percent_of_prediction	percent_of_DWPC	metapath
Remoxipride—DRD4—attention deficit hyperactivity disorder	0.29	0.342	CbGaD
Remoxipride—DRD3—attention deficit hyperactivity disorder	0.25	0.295	CbGaD
Remoxipride—DRD2—attention deficit hyperactivity disorder	0.173	0.204	CbGaD
Remoxipride—HTR2A—attention deficit hyperactivity disorder	0.134	0.158	CbGaD
Remoxipride—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.00506	0.227	CbGeAlD
Remoxipride—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.00269	0.121	CbGeAlD
Remoxipride—Alizapride—DRD2—attention deficit hyperactivity disorder	0.00193	0.285	CrCbGaD
Remoxipride—DRD4—brain—attention deficit hyperactivity disorder	0.00133	0.0595	CbGeAlD
Remoxipride—Amisulpride—DRD3—attention deficit hyperactivity disorder	0.00131	0.193	CrCbGaD
Remoxipride—DRD3—nervous system—attention deficit hyperactivity disorder	0.00122	0.0548	CbGeAlD
Remoxipride—DRD3—central nervous system—attention deficit hyperactivity disorder	0.00117	0.0527	CbGeAlD
Remoxipride—Sulpiride—DRD3—attention deficit hyperactivity disorder	0.00114	0.169	CrCbGaD
Remoxipride—DRD2—forebrain—attention deficit hyperactivity disorder	0.000951	0.0427	CbGeAlD
Remoxipride—DRD3—brain—attention deficit hyperactivity disorder	0.000933	0.0419	CbGeAlD
Remoxipride—Amisulpride—DRD2—attention deficit hyperactivity disorder	0.000904	0.134	CrCbGaD
Remoxipride—Sulpiride—DRD2—attention deficit hyperactivity disorder	0.00079	0.117	CrCbGaD
Remoxipride—SIGMAR1—midbrain—attention deficit hyperactivity disorder	0.000777	0.0349	CbGeAlD
Remoxipride—Amisulpride—HTR2A—attention deficit hyperactivity disorder	0.000699	0.103	CrCbGaD
Remoxipride—DRD2—midbrain—attention deficit hyperactivity disorder	0.000628	0.0282	CbGeAlD
Remoxipride—HTR2A—forebrain—attention deficit hyperactivity disorder	0.000627	0.0281	CbGeAlD
Remoxipride—SIGMAR1—cerebellum—attention deficit hyperactivity disorder	0.000601	0.027	CbGeAlD
Remoxipride—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000571	0.0256	CbGeAlD
Remoxipride—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.00053	0.0238	CbGeAlD
Remoxipride—DRD2—nervous system—attention deficit hyperactivity disorder	0.000516	0.0232	CbGeAlD
Remoxipride—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000497	0.0223	CbGeAlD
Remoxipride—SIGMAR1—brain—attention deficit hyperactivity disorder	0.000488	0.0219	CbGeAlD
Remoxipride—DRD2—cerebellum—attention deficit hyperactivity disorder	0.000486	0.0218	CbGeAlD
Remoxipride—HTR2A—midbrain—attention deficit hyperactivity disorder	0.000414	0.0186	CbGeAlD
Remoxipride—DRD2—brain—attention deficit hyperactivity disorder	0.000395	0.0177	CbGeAlD
Remoxipride—HTR2A—nervous system—attention deficit hyperactivity disorder	0.00034	0.0153	CbGeAlD
Remoxipride—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.000328	0.0147	CbGeAlD
Remoxipride—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.00032	0.0144	CbGeAlD
Remoxipride—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00031	0.0139	CbGeAlD
Remoxipride—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000299	0.0134	CbGeAlD
Remoxipride—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000292	0.0131	CbGeAlD
Remoxipride—HTR2A—brain—attention deficit hyperactivity disorder	0.00026	0.0117	CbGeAlD
Remoxipride—CYP2D6—brain—attention deficit hyperactivity disorder	0.000237	0.0106	CbGeAlD
Remoxipride—DRD4—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000146	0.00117	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000146	0.00117	CbGpPWpGaD
Remoxipride—DRD4—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000141	0.00113	CbGpPWpGaD
Remoxipride—DRD3—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00014	0.00112	CbGpPWpGaD
Remoxipride—DRD4—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000139	0.00111	CbGpPWpGaD
Remoxipride—DRD3—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.000139	0.00111	CbGpPWpGaD
Remoxipride—DRD4—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.000138	0.0011	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000137	0.0011	CbGpPWpGaD
Remoxipride—DRD4—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000135	0.00108	CbGpPWpGaD
Remoxipride—DRD3—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.000133	0.00107	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000132	0.00106	CbGpPWpGaD
Remoxipride—DRD2—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.000132	0.00105	CbGpPWpGaD
Remoxipride—DRD3—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.000131	0.00105	CbGpPWpGaD
Remoxipride—DRD3—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00013	0.00104	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000129	0.00104	CbGpPWpGaD
Remoxipride—DRD4—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000128	0.00102	CbGpPWpGaD
Remoxipride—DRD4—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000125	0.001	CbGpPWpGaD
Remoxipride—DRD3—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000124	0.000989	CbGpPWpGaD
Remoxipride—DRD3—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.000122	0.000981	CbGpPWpGaD
Remoxipride—DRD2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000122	0.000979	CbGpPWpGaD
Remoxipride—DRD3—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000122	0.000977	CbGpPWpGaD
Remoxipride—DRD2—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.000121	0.000971	CbGpPWpGaD
Remoxipride—DRD2—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.000121	0.000971	CbGpPWpGaD
Remoxipride—DRD4—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000121	0.000971	CbGpPWpGaD
Remoxipride—HTR2A—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00012	0.000963	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00012	0.000958	CbGpPWpGaD
Remoxipride—DRD4—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000119	0.000954	CbGpPWpGaD
Remoxipride—DRD2—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.000117	0.00094	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000117	0.00094	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000117	0.00094	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000117	0.000939	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000116	0.000925	CbGpPWpGaD
Remoxipride—DRD2—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.000115	0.000922	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000115	0.000921	CbGpPWpGaD
Remoxipride—DRD2—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.000114	0.000913	CbGpPWpGaD
Remoxipride—DRD3—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000114	0.00091	CbGpPWpGaD
Remoxipride—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000114	0.000909	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000113	0.000906	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000111	0.00089	CbGpPWpGaD
Remoxipride—HTR2A—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00011	0.000881	CbGpPWpGaD
Remoxipride—DRD4—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00011	0.000878	CbGpPWpGaD
Remoxipride—DRD2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000107	0.000855	CbGpPWpGaD
Remoxipride—HTR2A—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000106	0.00085	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000106	0.000848	CbGpPWpGaD
Remoxipride—HTR2A—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000105	0.000842	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000105	0.000839	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000105	0.000837	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000104	0.000834	CbGpPWpGaD
Remoxipride—DRD2—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.000104	0.00083	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000103	0.000825	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000103	0.000821	CbGpPWpGaD
Remoxipride—DRD2—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.000102	0.000816	CbGpPWpGaD
Remoxipride—DRD2—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.000101	0.000806	CbGpPWpGaD
Remoxipride—DRD2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	9.93e-05	0.000795	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	9.89e-05	0.000792	CbGpPWpGaD
Remoxipride—HTR2A—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	9.77e-05	0.000783	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	9.76e-05	0.000782	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	9.74e-05	0.00078	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	9.73e-05	0.00078	CbGpPWpGaD
Remoxipride—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	9.62e-05	0.00077	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	9.56e-05	0.000766	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	9.53e-05	0.000763	CbGpPWpGaD
Remoxipride—HTR2A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	9.46e-05	0.000758	CbGpPWpGaD
Remoxipride—DRD2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	9.45e-05	0.000757	CbGpPWpGaD
Remoxipride—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	9.34e-05	0.000748	CbGpPWpGaD
Remoxipride—HTR2A—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	9.3e-05	0.000745	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	9.23e-05	0.000739	CbGpPWpGaD
Remoxipride—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	9.19e-05	0.000736	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	9.15e-05	0.000733	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	9.11e-05	0.000729	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	9.07e-05	0.000727	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	9e-05	0.000721	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	8.98e-05	0.000719	CbGpPWpGaD
Remoxipride—DRD4—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	8.96e-05	0.000718	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	8.86e-05	0.00071	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	8.84e-05	0.000708	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	8.68e-05	0.000696	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	8.67e-05	0.000694	CbGpPWpGaD
Remoxipride—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	8.56e-05	0.000685	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	8.51e-05	0.000681	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	8.49e-05	0.00068	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	8.47e-05	0.000678	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	8.37e-05	0.00067	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	8.35e-05	0.000669	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	8.24e-05	0.00066	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	8.11e-05	0.000649	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	8.1e-05	0.000649	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	8.06e-05	0.000646	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	8e-05	0.000641	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	7.97e-05	0.000639	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	7.97e-05	0.000638	CbGpPWpGaD
Remoxipride—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	7.96e-05	0.000638	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	7.96e-05	0.000638	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	7.87e-05	0.000631	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	7.87e-05	0.00063	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	7.84e-05	0.000628	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	7.81e-05	0.000625	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	7.71e-05	0.000618	CbGpPWpGaD
Remoxipride—DRD4—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	7.68e-05	0.000615	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	7.42e-05	0.000594	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	7.33e-05	0.000587	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	6.97e-05	0.000558	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	6.94e-05	0.000555	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	6.86e-05	0.000549	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	6.82e-05	0.000546	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	6.64e-05	0.000531	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	6.63e-05	0.000531	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	6.53e-05	0.000523	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	6.5e-05	0.000521	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	6.48e-05	0.000519	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	6.4e-05	0.000512	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	6.37e-05	0.000511	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	6.27e-05	0.000503	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	6.17e-05	0.000494	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	6.17e-05	0.000494	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	6.1e-05	0.000488	CbGpPWpGaD
Remoxipride—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	6.09e-05	0.000488	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	6.09e-05	0.000488	CbGpPWpGaD
Remoxipride—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	6.07e-05	0.000486	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	6.07e-05	0.000486	CbGpPWpGaD
Remoxipride—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	6.03e-05	0.000483	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	6.03e-05	0.000483	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	6.02e-05	0.000482	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	5.99e-05	0.00048	CbGpPWpGaD
Remoxipride—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	5.99e-05	0.00048	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	5.93e-05	0.000475	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	5.9e-05	0.000473	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	5.89e-05	0.000472	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	5.85e-05	0.000468	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	5.81e-05	0.000465	CbGpPWpGaD
Remoxipride—DRD4—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	5.8e-05	0.000464	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	5.79e-05	0.000464	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	5.58e-05	0.000447	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	5.41e-05	0.000434	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	5.39e-05	0.000431	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	5.35e-05	0.000428	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	5.31e-05	0.000425	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	5.26e-05	0.000421	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	5.24e-05	0.000419	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	5.22e-05	0.000418	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	5.22e-05	0.000418	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	5.22e-05	0.000418	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	5.19e-05	0.000416	CbGpPWpGaD
Remoxipride—DRD3—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	5.15e-05	0.000412	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	5.15e-05	0.000412	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	5.13e-05	0.000411	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	5.13e-05	0.000411	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	5.03e-05	0.000403	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	4.89e-05	0.000392	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.78e-05	0.000383	CbGpPWpGaD
Remoxipride—HTR2A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	4.75e-05	0.00038	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	4.74e-05	0.000379	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	4.72e-05	0.000378	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.67e-05	0.000374	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	4.66e-05	0.000373	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.65e-05	0.000373	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.56e-05	0.000365	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.55e-05	0.000365	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.51e-05	0.000361	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.5e-05	0.00036	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.47e-05	0.000358	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.43e-05	0.000355	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	4.35e-05	0.000348	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	4.28e-05	0.000343	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	4.19e-05	0.000336	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.14e-05	0.000332	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	4.14e-05	0.000331	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.09e-05	0.000328	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	4.09e-05	0.000327	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.08e-05	0.000326	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.03e-05	0.000322	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.97e-05	0.000318	CbGpPWpGaD
Remoxipride—DRD2—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	3.94e-05	0.000316	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.94e-05	0.000315	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.88e-05	0.00031	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.81e-05	0.000305	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.66e-05	0.000293	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.6e-05	0.000289	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.58e-05	0.000286	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.56e-05	0.000285	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.56e-05	0.000285	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.55e-05	0.000284	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.52e-05	0.000282	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.5e-05	0.00028	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.49e-05	0.000279	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.49e-05	0.000279	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.49e-05	0.000279	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.44e-05	0.000276	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.43e-05	0.000275	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.43e-05	0.000275	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.42e-05	0.000274	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.39e-05	0.000271	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.36e-05	0.000269	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.32e-05	0.000266	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	3.3e-05	0.000265	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.27e-05	0.000262	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.22e-05	0.000258	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.17e-05	0.000254	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.17e-05	0.000253	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.16e-05	0.000253	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.16e-05	0.000253	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.13e-05	0.00025	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.11e-05	0.000249	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	3.11e-05	0.000249	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.08e-05	0.000246	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	3e-05	0.00024	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.94e-05	0.000235	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.89e-05	0.000231	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.87e-05	0.000229	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.8e-05	0.000224	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.76e-05	0.000221	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.75e-05	0.00022	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.67e-05	0.000213	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.57e-05	0.000206	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.53e-05	0.000203	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.48e-05	0.000199	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.44e-05	0.000196	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.42e-05	0.000194	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.41e-05	0.000193	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.38e-05	0.00019	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.25e-05	0.00018	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.25e-05	0.00018	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.11e-05	0.000169	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.08e-05	0.000166	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.04e-05	0.000163	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.96e-05	0.000157	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.93e-05	0.000155	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.9e-05	0.000152	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.87e-05	0.00015	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.87e-05	0.00015	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.85e-05	0.000148	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.84e-05	0.000147	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.82e-05	0.000146	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.77e-05	0.000142	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	1.71e-05	0.000137	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.71e-05	0.000137	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.69e-05	0.000136	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	1.69e-05	0.000135	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.57e-05	0.000126	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.57e-05	0.000126	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.37e-05	0.00011	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.3e-05	0.000104	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.2e-05	9.65e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	1.04e-05	8.32e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	1.03e-05	8.26e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	9.39e-06	7.52e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.34e-06	6.68e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.38e-06	5.11e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.28e-06	5.03e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	4.45e-06	3.57e-05	CbGpPWpGaD
